Loading…
DBV Technologies S.A. is projected to rise to $20.37 by 2027, a +24% move from its current price of $16.49. DBVT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $15.97 | $16.49 | $17.02 | -0.03% |
| Jul 14 | $15.75 | $16.48 | $17.24 | -0.06% |
| Jul 15 | $15.59 | $16.48 | $17.41 | -0.08% |
| Jul 16 | $15.45 | $16.47 | $17.56 | -0.11% |
| Jul 17 | $15.33 | $16.47 | $17.69 | -0.14% |
| Jul 18 | $15.22 | $16.46 | $17.80 | -0.17% |
| Jul 19 | $15.12 | $16.46 | $17.91 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.12 | $16.46 | $17.91 | -0.19% |
| Week 2 | $14.57 | $16.43 | $18.51 | -0.39% |
| Week 3 | $14.16 | $16.39 | $18.98 | -0.58% |
| Week 4 | $13.82 | $16.36 | $19.38 | -0.78% |
| Week 5 | $13.52 | $16.33 | $19.73 | -0.97% |
| Week 6 | $13.25 | $16.30 | $20.05 | -1.16% |
| Week 7 | $13.01 | $16.27 | $20.35 | -1.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DBV Technologies S.A. is a clinical-stage biopharmaceutical company engaged in the research and development of epicutaneous immunotherapy products in France. Its work includes Viaskin Peanut, which has completed Phase 3 clinical trials for the treatment of peanut allergies; and Viaskin Milk, which is in Phase 1/2 for the treatment of IgE-mediated or cow’s milk protein allergy and eosinophilic esophagitis.
The company’s earlier-stage programs include celiac disease and it develops the Viaskin technology platform. It also has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for diagnosing non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A.
was incorporated in 2002 and is headquartered in Châtillon, France.
DBV Technologies S.A. (DBVT) is the asset with a current price of $16.08 and a market cap of $951.72M, ranking 2607. The horizon of the price forecast shows a Neutral stance for 2026 with an average of $16.08 and an ROI of 0%.
From 2027 onward, the outlook becomes bullish with rising averages (2027 avg $20.35; 2028 avg $24.53; 2029 avg $28.75; 2030 avg $31.52; 2031 avg $32.97; 2032 avg $33.78; 2033 avg $35.48; 2034 avg $45.69; 2035 avg $53.69; 2040 avg $69.80; 2050 avg $152.88) and increasingly higher ROIs (e.g., 2027 ROI 26.6%; 2028 52.5%; 2029 78.8%; 2030 96%; 2035 233.9%; 2040 334.1%; 2050 850.7%). The sentiment reflects a bullish tilt in the longer term, with accompanying max forecasts (2027 max $27.72; 2030 max $47.65; 2040 max $125.11; 2050 max $303.04).
A major floor 18.3% below — a decisive break under it would weaken the trend.
The nearest floor, 5.8% below — buyers have tended to step in here.
The nearest ceiling, 15.8% above — a clean break opens room to run.
A major ceiling 42.8% above — clearing it would confirm fresh momentum.
Key DBVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DBVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.46 | Buy | $16.39 | Buy |
| MA 10 | $16.22 | Buy | $16.32 | Buy |
| MA 20 | $16.32 | Buy | $16.50 | Sell |
| MA 50 | $17.80 | Sell | $17.52 | Sell |
| MA 100 | $19.34 | Sell | $18.17 | Sell |
| MA 200 | $18.07 | Sell | $17.03 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.11 | Neutral |
| Stoch RSI (14) | 67.88 | Neutral |
| CCI (20) | 22.01 | Neutral |
| Williams %R (14) | -49.14 | Info |
| MACD (12,26,9) | 0.17 | Buy |
| ROC (12) | 2.36 | Buy |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 50.86 | Neutral |
| TRIX (15) | -0.48 | Sell |
| Awesome (5,34) | -0.45 | Sell |
| Ultimate (7,14,28) | 51.44 | Neutral |
| Momentum (10) | 0.47 | Buy |
| Aroon Osc (25) | -12.00 | Sell |
| Hull MA (9) | 16.71 | Sell |
| ADX (14) | 17.61 | Neutral |
| ATR (14) | 0.51 | Info |
The 30-day technical picture shows a bullish overall tilt. RSI(14) is 40, indicating room to move before the typical overbought zone. The near-term moving averages place the price around the 50-day average of $17.89 and the 200-day average of $18.03, suggesting a measure of upward momentum yet to be fully unlocked.
The 30-day range spans from a low of $12.97 to a high of $19.94, with a near-term floor at $15.53 supporting the price and resistance at $19.10.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.53 | $16.49 | $21.25 | 0% | Neutral | |
| $15.96 | $20.37 | $27.66 | +24% | Bullish | |
| $18.53 | $24.45 | $34.63 | +48% | Bullish | |
| $21.04 | $28.54 | $41.77 | +73% | Bullish | |
| $22.31 | $31.02 | $46.67 | +88% | Bullish | |
| $22.85 | $32.49 | $50.07 | +97% | Bullish | |
| $22.81 | $33.12 | $52.15 | +101% | Bullish | |
| $23.19 | $34.35 | $55.14 | +108% | Bullish | |
| $29.10 | $43.92 | $71.78 | +166% | Bullish | |
| $33.52 | $51.52 | $85.60 | +212% | Bullish | |
| $39.66 | $66.22 | $117.86 | +302% | Bullish | |
| $74.23 | $143.46 | $282.03 | +770% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $15.53 | $16.49 | $19.96 | +0.00% |
| August 2026 | $13.68 | $16.21 | $19.79 | -1.67% |
| September 2026 | $13.45 | $16.08 | $19.88 | -0.86% |
| October 2026 | $13.98 | $16.83 | $21.04 | +4.68% |
| November 2026 | $14.12 | $17.10 | $21.57 | +1.60% |
| December 2026 | $13.71 | $16.70 | $21.25 | -2.30% |
Click any year to see its month-by-month DBVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DBVT is projected to trade between $15.53 and $21.25, averaging $16.49 — a potential gain of 0% from today's $16.49. A consolidation phase looks the most probable path here.
DBV Technologies S.A.'s 2027 outlook centres on $20.37, within a $15.96 to $27.66 range. That is up +24% on the projected 2026 average. That marks a +24% change versus current levels. Momentum favours further upside here.
By 2028, DBVT could reach as high as $34.63, with a base case around $24.45 and support toward $18.53 — roughly +48% from $16.49. Buyers look set to stay in control over this stretch.
Expect DBVT to range from $21.04 to $41.77 through 2029. The $28.54 average target implies a +73% move from current prices. That is up +17% on the projected 2028 average. Momentum favours further upside here.
The DBVT price prediction for 2030 points to an average of $31.02 (low $22.31, high $46.67) — a potential gain of +88% on today's $16.49. Buyers look set to stay in control over this stretch.
In 2031, DBVT is projected to trade between $22.85 and $50.07, averaging $32.49 — a potential gain of +97% from today's $16.49. That is up +5% on the projected 2030 average. Momentum favours further upside here.
DBV Technologies S.A.'s 2032 outlook centres on $33.12, within a $22.81 to $52.15 range. That is up +2% on the projected 2031 average. That marks a +101% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DBVT could reach as high as $55.14, with a base case around $34.35 and support toward $23.19 — roughly +108% from $16.49. Momentum favours further upside here.
Expect DBVT to range from $29.10 to $71.78 through 2034. The $43.92 average target implies a +166% move from current prices. That is up +28% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DBVT price prediction for 2035 points to an average of $51.52 (low $33.52, high $85.60) — a potential gain of +212% on today's $16.49. Momentum favours further upside here.
In 2040, DBVT is projected to trade between $39.66 and $117.86, averaging $66.22 — a potential gain of +302% from today's $16.49. That is up +29% on the projected 2035 average. Buyers look set to stay in control over this stretch.
DBV Technologies S.A.'s 2050 outlook centres on $143.46, within a $74.23 to $282.03 range. That is up +117% on the projected 2040 average. That marks a +770% change versus current levels. Momentum favours further upside here.
Investing $1,000 in DBVT today (≈ 60.642814 DBVT) could be worth
$8,700.09
+$7,700.09 (+770%) by 2050 · US Dollar
Based on the average projected DBVT price of $143.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DBVTwould be worth at today's price.
$1,000 invested in DBVT on Jul 10, 2025 (≈ 92.302015 DBVT) would be worth
$1,522.06
+$522.06 (+52.2%) today · 1.52× · US Dollar
Based on a DBVT entry price of $10.83 vs. today's $16.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.82 | $1,042.35 | +4.2% |
| 1 month ago | $16.04 | $1,028.05 | +2.8% |
| 3 months ago | $20.59 | $800.87 | -19.9% |
| 6 months ago | $17.93 | $919.69 | -8.0% |
| 1 year ago | $10.83 | $1,522.06 | +52.2% |
| All time (5.0y) ago | $10.48 | $1,573.47 | +57.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DBVT forecast.
Our base-case forecast reaches $33.00 around 2032.
Implied market cap at $33.00: $1.95B
Longer-range forecasts point to a substantial upside, with the 2030 average price of $31.52 and a 96% ROI. The trajectory continues higher through 2040 (avg $69.80; ROI 334.1%) and into 2050 (avg $152.88; ROI 850.7%). The year-by-year path includes 2027 avg $20.35 (ROI 26.6%), 2028 avg $24.53 (ROI 52.5%), 2029 avg $28.75 (ROI 78.8%), 2031 avg $32.97 (ROI 105%), and 2035 avg $53.69 (ROI 233.9%).
These figures illustrate a rising long-run outlook, tempered by the uncertainty inherent in future projections. While the path shows strong potential, these are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
2030 avg $31.52; min $22.57; max $47.65; ROI 96%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages: 2027 avg $20.35 (ROI 26.6%), 2028 avg $24.53 (ROI 52.5%), 2029 avg $28.75 (ROI 78.8%), 2030 avg $31.52 (ROI 96%), 2035 avg $53.69 (ROI 233.9%), 2040 avg $69.80 (ROI 334.1%), and 2050 avg $152.88 (ROI 850.7%). However, these are estimates and not guarantees.
Yes. The forecast shows a 2040 max of $125.11, with earlier years max at $47.65 (2030) and $75.11 (2034). The 2040 max exceeds $100, reaching $125.11.
Current price: $16.08; Market cap: $951.72M.
30-day range low $12.97, high $19.94.
DBV Technologies S.A. Community Discussion
0Share your DBV Technologies S.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.